The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s drug screening market report forecasts the drug screening market size to grow to $12.29 Billion by 2027, with a CAGR (compound annual growth rate) of more than 13%.

Learn More On The Drug Screening Market Report 2023 – https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Drug Screening Market Size Forecast
The global drug screening market is expected to grow from $6.62 billion in 2022 to $7.51 billion in 2023 at a compound annual growth rate (CAGR) of 13.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The drug screening market size is expected to grow to $12.29 billion in 2027 at a CAGR of 13.1%.

North America held the largest drug screening market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Drug Screening Market Driver ­– Growth In Drug And Alcohol Consumption
For instance, in June 2019 & 2020, according to a report published by the United Nations Office on Drugs and Crime (UNODC), 35 million people globally suffer from drug use disorders and require treatment services. The severity and complexity of the world drug situation are increasing, revealing that the number of people who use drugs is now 30% higher than in 2009. The pandemic effects also ramp up drug risks, as cannabis intake by youth had increased by as much as four times in parts of the world. Therefore, growing drug and alcohol consumption is driving the growth of the drug screening market.

Request for A Sample Of The Global Drug Screening Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6369&type=smp

Key Drug Screening Market Trend – Developing Innovative Products
Major companies operating in the drug screening market are focusing on providing innovative products to meet fast-growing industry demand and strengthen their market position. Additionally, due to COVID, there was a sudden change in the drug screening approach, which changed the screening methodologies and pushed the innovation and new product development by companies. Companies are striving to develop new products such as a new drug test that is more effective and can be widely used by laboratories. For instance,in November 2020, Axion BioSystems, a US-based life science company, launched the Maestro ZHT high-throughput screening technology, utilizing their knowledge of live-cell equipment to give drug discovery and development a unique perspective. The Maestro ZHT tackles the challenges of finding and evaluating new candidates, capturing complex biology with a straightforward assay, and minimizing cost, time, and the waste of priceless antibodies and cells with a simple, automated, real-time, live-cell assay.

Drug Screening Market Segment
1) By Products: Rapid Testing Devices, Consumables, Other Products
2) By Sample Type: Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types
3) By End User: Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges

Drug Screening Market Major Players and Strategies
Major players in the drug screening market are LabCorp, Quest Diagnostics, Alere, OraSure, Alfa Scientific Designs, Thermo Fisher Scientific, Drägerwerk, LifeLoc, Omega Laboratories, Premier Biotech, Intoximeters, Sciteck Inc., Synens SAS, AccuSource Inc., and Creative Diagnostics.

In January 2020, StemBioSys, Inc., a Texas-based company involved in the development, manufacturing and distribution of life science tools acquired a majority stake in CarTox, Inc. for an undisclosed amount. This acquisition is expected to boost the company’s product portfolio in the drug screening and drug toxicology sector and contribute to its strategy to expand its business presence across the globe. CarTox, Inc. is a Michigan-based developer and manufacturer of drug screening and drug toxicology solutions.

The Drug Screening Global Market Report 2023 covers regional data on drug screening market size, drug screening market trends and drivers, opportunities, strategies, and drug screening market competitor analysis. The countries covered in the drug screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Drug screening is an approach used for drug testing, identified and optimized for clinical trials used in the analysis of blood, urine, hair, or saliva to detect the presence of chemicals and pollutants and other illicit substance left in the body as a result of drug usage.

View More Reports Related To The Drug Screening Market –
Drugs For Erectile Dysfunction Global Market Report 2023
Drugs For Immunotherapy Global Market Report 2023
Carrier Screening Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: